Abstract
The prophylactic and therapeutic activities of ketoconazole were evaluated in rats inoculated intravaginally with Candida albicans. Daily doses of 2.5 mg/kg initiated 48 h before challenge and continued for 48 h thereafter protected 80% of the rats against infection. A similar result in rats with established infection was attained with daily doses of 5.0 mg/kg.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bisschop M. P., Merkus J. M., Scheygrond H., Van Cutsem J., van de Kuy A. Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol. 1979 Aug;9(4):253–259. doi: 10.1016/0028-2243(79)90065-0. [DOI] [PubMed] [Google Scholar]
- Borgers M., Van den Bossche H., De Brabander M. The mechanism of action of the new antimycotic ketoconazole. Am J Med. 1983 Jan 24;74(1B):2–8. doi: 10.1016/0002-9343(83)90507-7. [DOI] [PubMed] [Google Scholar]